Objective: Identify private sector data sources with clinical and laboratory data that can be shared with local public health STD surveillance agencies for assessment of STD-related care, development of cost-efficient screening guidelines, and evaluation of preventable STD-related outcomes.
Methods: To assess age-specific CT/NG screening coverage at the program and provider level, we analyzed Family PACT program administrative client enrollment and provider claims data from 2003-2012. To assess CT/NG prevalence rates, we merged Quest Diagnostics data with the administrative data to determine relative case yields by age. We will also present examples of other CT/NG prevalence monitoring efforts based on Kaiser Permanente Northern California (KPNC) chlamydia and gonorrhea data, and national/state-level Lab Corp data. To estimate the burden of pelvic inflammatory disease, we used Family PACT claims-based ICD-9/NDC/CPT4 codes, as well as KPNC PID clinical encounter data, and present examples of other approaches with Group Health Cooperative and Market Scan data sources.
Results: CT/NG screening rates have increased across all data sources and all age groups. CT/NG prevalence monitoring trends across administrative data sources from multiple private sector data sources demonstrate similar and consistent age and race disparities to those seen in case-based surveillance data. Administrative data-based PID burden exceeds that seen in mandated case reports but for some sources showed declining trends coincident with increases in screening coverage.
Conclusions: Analysis of program-specific and population-based administrative data on STD-related clinical and laboratory data have been very useful for targeting programs and providers to improve cost-efficient screening of young women, reduce over-screening in low prevalence populations, and demonstrate impact of increased access to STD services on reduced reproductive sequelae. Background: